University of Maryland School of Medicine: Single Dose Typhoid Conjugate Vaccine Provides Lasting Efficacy in Children
January 26, 2024
January 26, 2024
BALTIMORE, Maryland, Jan. 26 (TNSres) -- The University of Maryland School of Medicine issued the following news:
* * *
First Study in Africa Found TCV Provided More than Four Years of Protection in Those Ages 9 Months & Older
* * *
A single dose of the typhoid conjugate vaccine, Typbar TCV(R), provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study conducted by researchers a . . .
* * *
First Study in Africa Found TCV Provided More than Four Years of Protection in Those Ages 9 Months & Older
* * *
A single dose of the typhoid conjugate vaccine, Typbar TCV(R), provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study conducted by researchers a . . .